NO931955L - Reseptorer for leukemiinhiberende faktor - Google Patents
Reseptorer for leukemiinhiberende faktorInfo
- Publication number
- NO931955L NO931955L NO93931955A NO931955A NO931955L NO 931955 L NO931955 L NO 931955L NO 93931955 A NO93931955 A NO 93931955A NO 931955 A NO931955 A NO 931955A NO 931955 L NO931955 L NO 931955L
- Authority
- NO
- Norway
- Prior art keywords
- leukemi
- receptors
- inhibiting factor
- lif
- dnas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Reseptorproteiner for leukemiinhiberende faktor (LIF-R), DNA-er og ekspresjonsvektorer som koder for LIF-R, og fremgangsmåter for fremstilling av LIF-R som produkter fra dyrking av rekombinante celler.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62672590A | 1990-12-13 | 1990-12-13 | |
US67060891A | 1991-03-13 | 1991-03-13 | |
PCT/US1991/009112 WO1992010570A1 (en) | 1990-12-13 | 1991-12-05 | Leukemia inhibitory factor receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO931955D0 NO931955D0 (no) | 1993-05-28 |
NO931955L true NO931955L (no) | 1993-08-12 |
Family
ID=27090242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93931955A NO931955L (no) | 1990-12-13 | 1993-05-28 | Reseptorer for leukemiinhiberende faktor |
Country Status (9)
Country | Link |
---|---|
US (3) | US5284755A (no) |
EP (1) | EP0561960A1 (no) |
JP (1) | JPH06504438A (no) |
AU (1) | AU647566B2 (no) |
CA (1) | CA2097291A1 (no) |
FI (1) | FI932477A (no) |
IE (1) | IE63450B1 (no) |
NO (1) | NO931955L (no) |
WO (1) | WO1992010570A1 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705478A (en) * | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
US6028177A (en) * | 1991-10-04 | 2000-02-22 | Washington University | Methods of detecting single-chain forms of the glycoprotein hormone quartet |
US5262522A (en) * | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
JPH07508733A (ja) | 1992-07-01 | 1995-09-28 | アムラド・コーポレイション・リミテッド | 白血病抑制因子結合蛋白 |
WO1994007921A1 (en) * | 1992-09-25 | 1994-04-14 | Commonwealth Scientific And Industrial Research Organisation | Target binding polypeptide |
US6548065B1 (en) * | 1994-05-06 | 2003-04-15 | Immunex Corporation | Interleukin-15 receptors |
US5783672A (en) * | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
BR9506313A (pt) * | 1994-08-12 | 1997-08-05 | Univ Washington | Formas de cadeia simples do quarteto de hormônio de glicoproteína |
EP0871667A4 (en) * | 1994-11-18 | 1999-05-12 | Human Genome Sciences Inc | G-PROTEIN COUPLED RECEPTOR |
US5641655A (en) * | 1994-11-30 | 1997-06-24 | Zymogenetics, Inc. | Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide |
US6090575A (en) * | 1995-03-30 | 2000-07-18 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein coupled receptor GPR1 |
EP0817800A4 (en) * | 1995-03-30 | 1999-06-16 | Human Genome Sciences Inc | RECEPTORS COUPLED BY HUMAN G PROTEIN |
US5998164A (en) * | 1995-03-30 | 1999-12-07 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein coupled receptor GPRZ |
US5573762A (en) * | 1995-04-24 | 1996-11-12 | Genentech, Inc. | Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy |
KR0185334B1 (ko) * | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
US20050002902A1 (en) * | 1995-12-28 | 2005-01-06 | Liming Yu | Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections |
US6217858B1 (en) | 1997-02-11 | 2001-04-17 | Hadasit & Medical Research Services & Development Company, Ltd. | Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
US20030100046A1 (en) * | 1996-03-13 | 2003-05-29 | James W. Baumgartner | Testis-specific receptor |
US5792850A (en) * | 1996-05-23 | 1998-08-11 | Zymogenetics, Inc. | Hematopoietic cytokine receptor |
US6967092B1 (en) * | 1996-10-25 | 2005-11-22 | Mc Kearn John P | Multi-functional chimeric hematopoietic receptor agonists |
US6103501A (en) * | 1997-11-17 | 2000-08-15 | Washington University | Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof |
US6635256B1 (en) * | 1998-10-19 | 2003-10-21 | Washington University | Glycoprotein hormone compositions comprising two β subunits and methods of use thereof |
EP2105446B1 (en) | 1998-09-23 | 2013-08-14 | ZymoGenetics, Inc. | Cytokine receptor zalpha11 |
US6913749B2 (en) * | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
US20020064820A1 (en) * | 2000-03-13 | 2002-05-30 | Jean-Michel Dayer | Apo-A-I regulation of T-cell signaling |
JP2003532418A (ja) * | 2000-05-12 | 2003-11-05 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | G−タンパク質シグナルの新規調整剤 |
AU2001273032A1 (en) | 2000-06-26 | 2002-01-08 | Zymogenetics Inc. | Cytokine receptor zcytor17 |
US7265208B2 (en) * | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
WO2003020906A2 (en) * | 2001-08-31 | 2003-03-13 | Abmaxis, Inc. | Multivalent protein conjugate with multiple ligand-binding domains of receptors |
EP2840089A1 (en) | 2002-01-18 | 2015-02-25 | ZymoGenetics, Inc. | Cytokine receptor zcytor17 multimers |
EP2295455A1 (en) | 2002-04-19 | 2011-03-16 | ZymoGenetics, L.L.C. | Cytokine receptor |
US7879621B2 (en) * | 2003-05-08 | 2011-02-01 | Phynexus, Inc. | Open channel solid phase extraction systems and methods |
US7413900B2 (en) * | 2005-10-31 | 2008-08-19 | President And Fellows Of Harvard College | Immortalized fibroblasts |
US20080118524A1 (en) * | 2006-10-20 | 2008-05-22 | Stefan Persson | Anti-IgE Vaccines |
WO2020018932A1 (en) * | 2018-07-20 | 2020-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Soluble polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US4675285A (en) * | 1984-09-19 | 1987-06-23 | Genetics Institute, Inc. | Method for identification and isolation of DNA encoding a desired protein |
US5391485A (en) * | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
US5071972A (en) * | 1986-01-31 | 1991-12-10 | Genetics Institute, Inc. | DNA sequences encoding novel thrombolytic proteins |
EP0276846A3 (en) * | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Colony-stimulating factor derivatives |
ATE140963T1 (de) * | 1988-01-22 | 1996-08-15 | Zymogenetics Inc | Verfahren zur herstellung von sekretierten rezeptoranalogen |
US5262522A (en) * | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
JPH07508733A (ja) * | 1992-07-01 | 1995-09-28 | アムラド・コーポレイション・リミテッド | 白血病抑制因子結合蛋白 |
-
1991
- 1991-12-05 WO PCT/US1991/009112 patent/WO1992010570A1/en not_active Application Discontinuation
- 1991-12-05 EP EP92901653A patent/EP0561960A1/en not_active Ceased
- 1991-12-05 CA CA002097291A patent/CA2097291A1/en not_active Abandoned
- 1991-12-05 JP JP4502381A patent/JPH06504438A/ja active Pending
- 1991-12-05 AU AU91229/91A patent/AU647566B2/en not_active Ceased
- 1991-12-12 IE IE433391A patent/IE63450B1/en not_active IP Right Cessation
-
1992
- 1992-09-11 US US07/943,843 patent/US5284755A/en not_active Expired - Fee Related
-
1993
- 1993-05-28 NO NO93931955A patent/NO931955L/no unknown
- 1993-05-31 FI FI932477A patent/FI932477A/fi unknown
- 1993-09-10 US US08/119,780 patent/US5420247A/en not_active Expired - Lifetime
-
1994
- 1994-11-29 US US08/347,003 patent/US5785967A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5284755A (en) | 1994-02-08 |
CA2097291A1 (en) | 1992-06-14 |
AU9122991A (en) | 1992-07-08 |
NO931955D0 (no) | 1993-05-28 |
FI932477A (fi) | 1993-06-11 |
IE914333A1 (en) | 1992-06-17 |
JPH06504438A (ja) | 1994-05-26 |
AU647566B2 (en) | 1994-03-24 |
IE63450B1 (en) | 1995-04-19 |
US5420247A (en) | 1995-05-30 |
FI932477A0 (fi) | 1993-05-31 |
US5785967A (en) | 1998-07-28 |
EP0561960A1 (en) | 1993-09-29 |
WO1992010570A1 (en) | 1992-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO931955L (no) | Reseptorer for leukemiinhiberende faktor | |
EP0318296A3 (en) | Interleukin-1 receptors | |
DE69024291T2 (de) | Rezeptoren für Tumornekrosisfaktor-alpha und -beta | |
IL98205A0 (en) | Type ii interleukin-1 receptors | |
ATE215601T1 (de) | Rezeptoren der steroid/thyroid superfamilie von rezeptoren | |
NZ336146A (en) | Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase | |
DE68928043T2 (de) | Interleukin-4-Rezeptoren | |
ATE350475T1 (de) | Rezeptor an der oberfläche von aktivierten t- zellen:act4 | |
DE69130506T2 (de) | Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften | |
EP0538404A4 (en) | Fibroblast growth factor receptors | |
DK0759942T3 (da) | Interleukin-15-receptorer | |
ATE118036T1 (de) | Interleukin-7-rezeptoren. | |
DE3851035D1 (de) | Interleukin-7. | |
IT8820117A0 (it) | Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina. | |
ES8800353A1 (es) | Procedimiento de clonacion de factor humano viii-r. | |
ATE123812T1 (de) | Rezeptoren für granulozytenkolonien stimulierenden faktor. | |
WO1995016036A3 (en) | IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF | |
NO974713D0 (no) | Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider | |
IL86710A0 (en) | Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same | |
ZA916106B (en) | Cloning and expression of a rhoptry-associated protein of p.falciparum |